Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
August 25, 2021 9:14 AM 2 min read

5 Penny Stocks Insiders Are Buying

by Lisa Levin Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Boxlight

The Trade: Boxlight Corporation (NASDAQ:BOXL) President Mark Starkey acquired a total of 20000 shares at an average price of $2.31. To acquire these shares, it cost $46,200.00.

What’s Happening: Boxlight recently reported better-than-expected Q2 results.

What Boxlight Does: Boxlight is an education technology company. It develops, sells and services interactive classroom solutions for the education market.

HCW Biologics

The Trade: HCW Biologics Inc. (NASDAQ:HCWB) Senior Vice President of Business Development Lee Flowers acquired a total of 13458 shares shares at an average price of $4.03. The insider spent $54,225.86 to buy those shares.

What’s Happening: HCW Biologics recently reported a Q2 net loss of $2.8 million.

What HCW Biologics Does: HCW Biologics Inc is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases.

Reed's

The Trade: Reed's, Inc. (NASDAQ:REED) Director John Bello acquired a total of 135000 shares at an average price of $0.72. To acquire these shares, it cost $97,200.00.

What’s Happening: Reed's recently reported worse-than-expected Q2 sales.

What Reed's Does: Reed's Inc sells Ginger Beer brand. The company's portfolio of handcrafted, all-natural beverages sold in over 40,000 outlets nationwide including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores and on-premise locations including bars and restaurants.

Amplify Energy

The Trade: Amplify Energy Corp. (NYSE:AMPY) Director David Proman acquired a total of 15000 shares shares at an average price of $3.36. The insider spent $50,379.00 to buy those shares.

What’s Happening: The company, earlier during the month, reported a narrower quarterly loss.

What Amplify Energy Does: Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation and production of oil and natural gas properties in the United States.

ReShape Lifesciences

The Trade: ReShape Lifesciences Inc. (NASDAQ:RSLS) Chief Financial Officer Thomas Stankovich acquired a total of 15000 shares at an average price of $3.22. To acquire these shares, it cost $48,285.00.

What’s Happening: The company recently reported Q2 revenue of $3.5 million, up from $1.7 million in the year-ago period.

What ReShape Lifesciences Does: Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPenny StocksInsider TradesIntraday UpdateMarketsTrading IdeasPenny Stocks Insider Buying
AMPY Logo
AMPYAmplify Energy Corp
$6.131.09%
Overview
BOXL Logo
BOXLBoxlight Corp
$1.29-%
HCWB Logo
HCWBHCW Biologics Inc
$0.5392-2.00%
REED Logo
REEDReed's Inc
Not Available-%
AMPY Logo
AMPYAmplify Energy Corp
$6.131.09%
Overview
BOXL Logo
BOXLBoxlight Corp
$1.29-%
HCWB Logo
HCWBHCW Biologics Inc
$0.5392-2.00%
REED Logo
REEDReed's Inc
Not Available-%
Comments
Loading...